Small dense low-density lipoprotein and its role as an independent predictor of cardiovascular disease
Explore this paper's citation graph
Summary
The plasma concentration of small dense low-density lipoprotein is likely to be more informative than relative low- density lipop protein particle size, and although methods are available for quantitation of this subfraction, there is considerable room for improvement.
- Type
- article
- Published
- 2006-08-01
- Cited by
- 125
- References
- 49
- OpenAlex
- https://openalex.org/W16832165
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:24262107
Keywords
Humanities, Political science, Art
References
- Atherogenic, dense low-density lipoproteins. Pathophysiology and new therapeutic approaches.
- The metabolic syndrome: time for a critical appraisal
- Lipoprotein-associated phospholipase A2 as a target of therapy
- Cardiovascular disease with diabetes or the metabolic syndrome: should statins or fibrates be first line lipid therapy?
- Regulation of small dense LDL concentration in Korean and Scottish men and women.
- Low-density lipoprotein size and subclasses are markers of clinically apparent and non-apparent atherosclerosis in type 2 diabetes.
- Troglitazone increases the resistance of low density lipoprotein to oxidation in healthy volunteers
- Insulin resistance, LDL particle size, and LDL susceptibility to oxidation in pediatric kidney and liver recipients.
- Effects of rosiglitazone alone and in combination with atorvastatin on the metabolic abnormalities in type 2 diabetes mellitus.
- Type 2 diabetes, dyslipidemia, and vascular risk: rationale and evidence for correcting the lipid imbalance.
- Metabolic origins and clinical significance of LDL heterogeneity DOI 10.1194/jlr.R200004-JLR200
- Effects of Pioglitazone on Lipoproteins, Inflammatory Markers, and Adipokines in Nondiabetic Patients with Metabolic Syndrome
- Adipocytokines and VLDL metabolism: independent regulatory effects of adiponectin, insulin resistance, and fat compartments on VLDL apolipoprotein B-100 kinetics?
- Diabetic dyslipidaemia: from basic research to clinical practice*
- Predictors of low-density lipoprotein particle size in a high-risk African-American population.
- Atherogenic lipoprotein subfraction profile in preeclamptic women with and without high triglycerides: different pathophysiologic subsets in preeclampsia.
- Lack of Association Between Carotid Intima-Media Thickness and PAF-Acetylhydrolase Mass and Activity in Patients with Primary Hyperlipidemia
- Effect of statins on LDL particle size in patients with familial combined hyperlipidemia: a comparison between atorvastatin and pravastatin.
- Phospholipase A2 and small, dense low-density lipoprotein
- Lipoprotein-associated phospholipase A2 as a biomarker for coronary disease and stroke
Cited by
- Influence of obesity on atherogenic dyslipidemia in women with polycystic ovary syndrome
- Pediatric nonalcoholic fatty liver disease, metabolic syndrome and cardiovascular risk.
- Investigation of the effect of short-term supplementation with curcuminoids on circulating small dense low-density lipoprotein concentrations in obese dyslipidemic subjects: A randomized double-blind placebo-controlled cross-over trial
- Impact of dietary fat quantity and quality in type 2 diabetes with emphasis on marine n-3 fatty acids
- Chronic consumption of an inositol-enriched carob extract improves postprandial glycaemia and insulin sensitivity in healthy subjects: A randomized controlled trial.
- Ketogenic diet in epileptic children: impact on lipoproteins and oxidative stress
- Who needs to care about small, dense low‐density lipoproteins?
- Epidemiología Inversa: baja concentración de LDL modificadas y morbimortalidad cardiovascular en pacientes en hemodiálisis
- Lipid phenotypes at the extremes of high-density lipoprotein cholesterol: The very large database of lipids-9.
- LDL Particle Size and Reactive Oxygen Metabolites in Dyslipidemic Patients
- Fructose consumption: potential mechanisms for its effects to increase visceral adiposity and induce dyslipidemia and insulin resistance
- Amount of hepatic fat predicts cardiovascular risk independent of insulin resistance among Hispanic-American adolescents
- ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS).
- Sleep Status and Low-Density Lipoprotein Particle Size in a General Japanese Female Population: The Mima Study
- Molecular structure of low density lipoprotein: current status and future challenges
- Atherogenic dyslipidemia and oxidative stress: a new look.
- Association of fasting and nonfasting serum triglycerides with cardiovascular disease and the role of remnant-like lipoproteins and small dense LDL
- Aggregatibacter actinomycetemcomitans induces MMP-9 expression and proatherogenic lipoprotein profile in apoE-deficient mice.
- Ezetimibe plus fenofibrate: a new combination therapy for the management of mixed hyperlipidaemia?
- Effects of marine n-3 fatty acid supplementation on lipoprotein subclasses measured by nuclear magnetic resonance in subjects with type II diabetes
Related papers
No related papers recorded.